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Background and Purpose  The literature indicates that obstructive sleep apnea (OSA) in-
creases the risk of ischemic stroke. However, the causal relationship between OSA and isch-
emic stroke is not well established. This study examined whether preexisting OSA symptoms 
affect the onset of acute ischemic stroke.
Methods  We investigated consecutive patients who were admitted with acute ischemic 
stroke, using a standardized protocol including the Berlin Questionnaire on symptoms of OSA 
prior to stroke. The collected stroke data included the time of the stroke onset, risk factors, and 
etiologic subtypes. The association between preceding OSA symptoms and wake-up stroke 
(WUS) was assessed using multivariate logistic regression analysis.
Results  We identified 260 subjects with acute ischemic strokes with a definite onset time, of 
which 25.8% were WUS. The presence of preexisting witnessed or self-recognized sleep apnea 
was the only risk factor for WUS (adjusted odds ratio=2.055, 95% confidence interval=1.035– 
4.083, p=0.040).
Conclusions  Preexisting symptoms suggestive of OSA were associated with the occurrence of 
WUS. This suggests that OSA contributes to ischemic stroke not only as a predisposing risk fac-
tor but also as a triggering factor. Treating OSA might therefore be beneficial in preventing 
stroke, particularly that occurring during sleep.
Key Words   obstructive sleep apnea, wake-up stroke, questionnaires.
Increased Risk of Ischemic Stroke during Sleep 
in Apneic Patients
INTRODUCTION
Obstructive sleep apnea (OSA) is a recently identified risk factor for stroke, which is impor-
tant since the condition is both highly prevalent and treatable. The recent revised stroke 
prevention guideline provided new recommendations for secondary stroke prevention as 
well as commenting on sleep apnea.1 However, it remains unclear whether the relationship 
between OSA and stroke is causative or merely a correlation. The association between OSA 
and stroke is often explained by the sharing of common comorbid conditions such as hy-
pertension, diabetes mellitus, dyslipidemia, obesity, and atrial fibrillation, which are well-
established stroke risk factors. Although more recent studies showed that OSA is an indepen-
dent risk factor for stroke,2,3 these studies were not designed to identify the pathophysiologic 
mechanism linking OSA to stroke. Moreover, whether treating OSA decreases the risk of 
incident stroke also needs remains to be clarified.4
If OSA is a direct triggering factor for stroke, stroke might occur more frequently during 
sleep in people with OSA. Stroke occurring during sleep or wake-up stroke (WUS) report-
edly constitute 13.5–38.9% of cases of ischemic stroke.5-13 Patients who wake up with stroke 
symptoms are often not eligible for thrombolytic therapy, since administering IV tissue 
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plasminogen activator is restricted to 4.5 hours following the 
onset of stroke symptoms. Some studies found that WUS 
patients had a greater initial stroke severity and were more 
likely to experience a poor outcome,5,9 while many studies 
have found that risk-factor profiles do not differ significantly 
between WUS and non-WUS. There are several reports of 
dyslipidemia being more frequent in WUS.13-15 Lower blood 
pressure was suggested as a risk factor for WUS,11 but this 
finding has not been replicated in other studies. Four12,15-17 
of six11-13,15-17 studies that assessed OSA as a stroke risk factor 
found that habitual snoring or a higher apnea-hypopnea in-
dex in poststroke polysomnography (PSG) was more fre-
quent among WUS patients (Supplementary Table 1 in the 
online-only Data Supplement). However, poststroke PSG 
cannot be used to diagnose preexisting OSA due to the high 
prevalence of new-onset OSA following acute stroke. Based 
on the above-mentioned considerations, the present study 
examined whether preexisting symptoms of OSA are associ-
ated with the occurrence of WUS. 
METHODS
We consecutively evaluated adult patients who were admit-
ted with acute ischemic stroke in Gangwon Comprehensive 
Stroke Center (CSC) in Kangwon National University Hos-
pital between December 1, 2013 and April 30, 2015. Gang-
won CSC is 1 of 11 regional CSCs in South Korea, and it 
covers the Gangwon province. This center was established in 
2009 with support from the Ministry of Health and Welfare.
We included patients with acute ischemic stroke present-
ing via the emergency room (ER) within 7 days from the 
stroke onset. Patients were excluded if they had experienced 
a transient ischemic attack and hemorrhagic stroke. We also 
excluded those in whom the ischemic stroke occurred dur-
ing hospitalization or if the patient was admitted via an out-
patient clinic, since the intake interview could be standard-
ized only when the patient initially presented to the ER. We 
used a standardized protocol to collect clinical information 
associated with stroke, laboratory findings, and preexisting 
symptoms of OSA. Patients or their caregivers were asked to 
provide a careful description of the situation and timing of 
stroke onset. The strokes were classified into WUS and non-
WUS based on the time of stroke onset, where WUS was 
defined as the symptoms being recognized upon awakening 
by a witness or by the patient, and non-WUS was defined as 
the symptoms being recognized while performing daily ac-
tivities. The strokes were categorized into the following sub-
types using the Trial of Org 10172 in Acute Stroke Treatment 
(TOAST) criteria: large-artery atherosclerosis, cardioembo-
lism, small-vessel occlusion, other determined etiology, and 
undetermined etiology. The routine workup for acute isch-
emic stroke was performed using brain CT, MRI, carotid ul-
trasonography, and transthoracic echocardiography. Selected 
patients underwent 24-hour Holter monitoring and trans-
esophageal echocardiography when embolic infarction was 
strongly suggested and the source could not be found using 
the aforementioned routine tests. 
The presence of OSA symptoms prior to the stroke was 
assessed by applying the Korean version of the Berlin Ques-
tionnaire18 to either the patient or caregiver. All question-
naires were administered by a single interviewer affiliated to 
Gangwon CSC while being blinded to clinical information, 
including the stroke onset time. This questionnaire compris-
es 11 questions grouped into 3 categories. Category 1 consists 
of five questions covering snoring, witnessed or self-recog-
nized apnea, and the frequency of such events. Category 2 
consists of four questions on daytime sleepiness; we modified 
the question “Have you ever fallen asleep while driving?” to 
“Have you had trouble staying awake while driving, eating 
meals, or engaging in social activity?” because most of the 
patients answered “I don’t drive” in our pilot study. Category 
3 consists of two questions concerning blood pressure and 
body mass index (BMI). Patients were considered to be at a 
high risk of sleep apnea when they conformed with at least 
two symptom categories.19 
Statistical analysis was used to compare the demographic 
and clinical variables between WUS and non-WUS patients. 
The chi-square test or Fisher’s exact test was used for categor-
ical variables, while the independent t-test was used for con-
tinuous variables including age, cholesterol, and BMI. Mul-
tivariate logistic regression analysis was used to assess the 
association between witnessed or self-recognized sleep apnea 
and WUS. The model was adjusted for potential confound-
ers including sex, age, history of prior stroke, hypertension, 
diabetes mellitus, smoking, hypercholesterolemia, and atrial 
fibrillation. We did not include obesity in the model due to 
the presence of a prior strong correlation with sleep apnea 
and BMI not differing significantly between WUS and non-
WUS patients. For multivariate analysis, age was categorized 
to three groups of <60, 60–75, and >75 years, while hyper-
cholesterolemia was considered to be present when total cho-
lesterol was higher than 240 mg/dL. 
The Statistical Package for Social Sciences (version 21 for 
Windows, IBM Corp., Armonk, NY, USA) was used for the sta-
tistical analyses. All reported p values are two-tailed, with p< 
0.05 defining the presence of statistical significance.
The study was approved by the Institutional Review Board 
of Kangwon National University Hospital (KNUH-2016-03-
007-001).
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RESULTS
In total, 298 patients with acute ischemic stroke met the in-
clusion criteria. We could not obtain answered questionnaires 
for 21 patients because 12 had severe medical complications, 
7 were transferred to other hospitals on the day of admission, 
and 2 patients had severe aphasia and no caregiver. Seven-
teen of the remaining 277 patients were excluded because 
the stroke onset could not be categorized into either WUS 
or non-WUS. Finally 260 patients were included in the final 
analysis: 67 (25.8%) in the WUS group and 193 (74.2%) in the 
non-WUS group (Fig. 1). The informants for the Berlin Ques-
tionnaire were the patients in 81 (31.2%) cases, cosleepers in 
67 (25.8%) cases, and other family members in 112 (43.1%) 
cases. There were positive replies to Category 1 questions on 
snoring and apnea in 83 (31.9%) patients, to Category 2 
questions on excessive daytime sleepiness in 21 (8.1%) pa-
tients, and to Category 3 questions on obesity and hyperten-
sion in 150 (57.7%) patients. Overall, 59 (22.7%) patients were 
considered at a high risk of sleep apnea based on the number 
of positive signs/symptoms in the different categories. 
The clinical characteristics of the WUS and non-WUS 
patients are compared in Table 1. Witnessed or self-recog-
nized sleep apnea was significantly more common in WUS 
Table 1. Clinical characteristics according to the time of stroke onset
Characteristics Total (n=260) WUS (n=67) non-WUS (n=193) p
Demographic variables
Sex, male 152 (58.5) 39 (58.2) 113 (58.5) 0.961
Age (year) 71.6±11.5 71.4±12.6 71.7±11.2 0.847
Stroke risk factors
Prior stroke 53 (20.4) 13 (19.4) 40 (20.7) 0.817
Hypertension 153 (58.8) 40 (59.7) 113 (58.5) 0.869
Diabetes mellitus 82 (31.5) 25 (37.3) 57 (29.5) 0.238
Smoking 86 (33.1) 25 (37.3) 61 (31.6) 0.392
Total cholesterol (mg/dL) 176.7±42.1 181.2±41.1 175.2±42.4 0.312
Atrial fibrillation 47 (18.1) 7 (10.4) 40 (20.7) 0.060
Body mass index (kg/m2) 23.9±3.50 24.0±3.47 23.8±3.51 0.650
Etiology based on TOAST classification
Large-artery atherosclerosis 136 (52.3) 38 (56.7) 98 (50.8) 0.402
Cardioembolism 63 (24.2) 11 (16.4) 52 (26.9) 0.083
Small-vessel occlusion 40 (15.4) 10 (14.9) 30 (15.5) 0.904
Other determined etiology 7 (2.7) 3 (4.5) 4 (2.1) 0.295
Undetermined etiology 14 (5.4) 5 (7.5) 9 (4.7) 0.382
Symptoms suggesting sleep breathing disorder †
Snoring 137 (52.7) 37 (55.2) 100 (51.8) 0.630
Sleep apnea 51 (19.6) 19 (28.3) 32 (16.6) 0.036*
Severity of stroke
NIHSS score 3 [1–5.75] 4 [2–9] 2 [1–4.5] 0.013*
Questionnaire informant
Cosleepers 67 (25.8) 15 (22.4) 52 (26.9) 0.463
Data are mean±standard deviation, n (%), or median [interquartile range] values.
*p<0.05, †Snoring, at least once a month; sleep apnea, witnessed or self-recognized sleep apnea at least once a month.
NIHSS: National Institute of Health Stroke Scale, TOAST: Trial of Org 10172 in Acute Stroke Treatment, WUS: wake-up stroke.
298 ischemic stroke
patients
277 eligible
patients
67 patients
with WUS
193 patients
with non-WUS
    21 excluded:
      12 patients–severe or complicated
      7 patients–transfer on the first day
      2 patients–aphasia without family member
    17 excluded:
      indefinite whether WUS or non-WUS
Fig. 1. Study subjects. WUS: wake-up stroke.
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patients than in non-WUS patients (28.3% versus 16.6%, p= 
0.036). However, the snoring and risk categorization for sleep 
apnea based on the Berlin Questionnaire did not differ signifi-
cantly between these two groups. Atrial fibrillation was mar-
ginally more frequent in non-WUS than in WUS (20.7% ver-
sus 10.4%, p=0.060). The National Institute of Health Stroke 
Scale (NIHSS) scores at admission were more severe in WUS 
than in non-WUS (median=4 [interquartile range=2–9] versus 
2 [1–4.5], p=0.013). None of the other demographic or stroke 
risk factors differed significantly between the two groups. Mul-
tivariate analysis confirmed that only sleep apnea was signifi-
cantly associated with WUS (odds ratio=2.055, 95% confi-
dence interval=1.035– 4.083, p=0.040) (Table 2). 
DISCUSSION
We found that sleep apnea prior to stroke was associated with 
WUS. This suggests that OSA not only influences chronic 
changes that predispose patients to stroke but also produces 
more acute changes directly resulting in stroke. Treating OSA 
might therefore be beneficial in preventing stroke, even in el-
derly patients with long-standing disease. Plausible mecha-
nisms for OSA-associated ischemic stroke include the imme-
diate effect of hypoxia, decreased cerebral blood flow, and 
the paradoxical embolism induced by apnea events, plaque 
disruption associated with vibration, and hypercoagulability 
that have been noted in OSA patients.20,21
Our finding that the incidence of stroke while awake was 
higher in those with atrial fibrillation supports the traditional 
idea that embolic stroke is more likely to occur while active.22 
In agreement with a few previous studies, the initial NIHSS 
score at admission was higher in WUS than in non-WUS. 
This could be due to not only the delay in detecting and treat-
ing stroke, but also being in a worse condition such as de-
creased systemic blood pressure or lower cerebral blood flow, 
or hypercoagulability during sleep.23-25 The association be-
tween OSA and WUS is more meaningful in this regard. 
Our study was subject to some limitations. The study had 
a cross-sectional design and the questionnaire was the only 
way to identify the presence of OSA symptoms preceding the 
onset of stroke, because poststroke PSG does not indicate 
preexisting OSA. Classifying a high versus a low risk of sleep 
apnea based on the category scores of the Berlin Question-
naire was reported to have low validity in the elderly, mainly 
due to hypertension being highly prevalent and the difficul-
ty of assessing sleepiness in the elderly. Simply using Cate-
gory 1 on snoring and apnea was more valid than using a 
high/low classification,26 supporting our results that WUS was 
associated with the presence of apnea rather than a high-risk 
classification. Witnessed sleep apnea had a high specificity 
and low sensitivity for significant OSA confirmed by PSG, 
whereas snoring had a high sensitivity and relatively low speci-
ficity.27 
Despite the validity issues, the prevalence of OSA symp-
toms in our study was comparable to the prevalence of PSG-
confirmed OSA in a previous study performed in Korea.28 
While our study was conducted in a single center, Kangwon 
National University Hospital is a teaching hospital that pro-
vides advanced specialty care and has a large catchment area 
that encompasses the province with easy access for patients. 
We therefore consider the data from a model to be less biased. 
However, the findings of this study need to be confirmed in 
larger-scale prospective cohort studies that apply PSG to 
evaluate underlying OSA and long-term follow-up in order to 
detect the occurrence of stroke and stroke onset time. 
In conclusion, preexisting symptoms of OSA were associ-
ated with the occurrence of WUS. This result has highly prac-
tical implications for preventing WUS and provides insight 
into the mechanism underlying how OSA influences the in-
cidence of stroke.
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Table 2. Odds ratios and confidence intervals for wake-up stroke in 
the multivariate analysis
Variables Odds ratio
Confidence interval
p
Lower Higher
Sleep apnea* 2.055 1.035 4.083 0.040
Sex (male) 0.679 0.333 1.384 0.287
Age 1.007 0.674 1.503 0.974
Prior stroke 0.923 0.442 1.931 0.833
Hypertension 0.958 0.517 1.777 0.893
Diabetes mellitus 1.371 0.739 2.544 0.317
Smoking 1.414 0.692 2.889 0.342
Hypercholesterolemia† 1.319 0.489 3.558 0.584
Atrial fibrillation 0.493 0.204 1.192 0.116
*Witnessed or self-recognized sleep apnea at least once a month, †Total 
cholesterol higher than 240 mg/dL. 
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